Danaher (DHR) Stock Forecast & Price Target

$275.20

-2.82 (-1.01%)

(As of 11:08 AM ET)

Danaher - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 18 Analyst Ratings

Sell
0

Hold
6

Buy
12

Based on 18 Wall Street analysts who have issued ratings for Danaher in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 6 have given a hold rating, and 12 have given a buy rating for DHR.

Consensus Price Target

$281.06
2.05% Upside

According to the 18 analysts' twelve-month price targets for Danaher, the average price target is $281.06. The highest price target for DHR is $315.00, while the lowest price target for DHR is $250.00. The average price target represents a forecasted upside of 2.05% from the current price of $275.20.

Get the Latest News and Ratings for DHR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Danaher and its competitors.

DHR Analyst Ratings Over Time

Type	Current Forecast 10/2/23 to 10/1/24	1 Month Ago 9/2/23 to 9/1/24	3 Months Ago 7/4/23 to 7/3/24	1 Year Ago 10/2/22 to 10/2/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	11 Buy rating(s)	11 Buy rating(s)	12 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$281.06	$278.94	$268.67	$290.47
Forecasted Upside	2.05% Upside	3.57% Upside	11.85% Upside	35.90% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

PANIC IN THE BANKS: 63 on the Brink of Collapse (Ad)

63 banks are on the edge, drowning in $517 BILLION of unrealized losses. Interest rates are skyrocketing, and these institutions are cracking under the pressure.

Click Here To Get Your FREE Guide Now!

DHR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DHR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Danaher Stock vs. The Competition

Type	Danaher	Multi-Sector Conglomerates Companies	S&P 500
Consensus Rating Score	2.65	2.74	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	0.33% Upside	14.02% Upside	6.15% Upside
News Sentiment Rating	Positive News See Recent DHR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/1/2024	Stephens 4 of 5 stars		Initiated Coverage	Overweight	$315.00	+13.30%
9/6/2024	Royal Bank of Canada 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$300.00 ➝ $300.00	+11.70%
8/27/2024	Wells Fargo & Company 3 of 5 stars	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$280.00	+4.16%
7/24/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$271.00 ➝ $278.00	+4.46%
7/24/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$270.00 ➝ $285.00	+6.91%
7/24/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$235.00 ➝ $250.00	-6.05%
Get the Latest News and Ratings for DHR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.
7/24/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$275.00 ➝ $280.00	+5.22%
7/24/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$290.00 ➝ $310.00	+16.16%
7/24/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$225.00 ➝ $250.00	-6.32%
7/24/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$270.00 ➝ $275.00	+4.10%
7/2/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$266.00 ➝ $260.00	+7.94%
6/3/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$295.00	+13.35%
4/24/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$280.00 ➝ $290.00	+16.02%
4/17/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$250.00 ➝ $280.00	+16.93%
2/1/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$260.00 ➝ $290.00	+20.88%
1/31/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$240.00 ➝ $270.00	+10.23%
12/20/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$250.00 ➝ $270.00	+17.71%
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Peer Perform
5/1/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$300.00	+26.63%
4/27/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$310.00 ➝ $275.00	+18.29%
4/26/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Larew Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
4/26/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$300.00 ➝ $270.00	+16.38%
1/25/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$340.00 ➝ $320.00	+17.83%
10/24/2022	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$325.00	+34.67%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:23 AM ET.

Should I Buy Danaher Stock? DHR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, September 29, 2024. Please send any questions or comments about these Danaher pros and cons to contact@marketbeat.com.

Danaher
Bull Case

Here are some ways that investors could benefit from investing in Danaher Co.:

Danaher Co. has shown consistent growth in its stock price, currently trading at $276.03, with a 52-week high of $281.70, indicating positive momentum.
The company's diverse product portfolio across professional, medical, industrial, and commercial sectors provides stability and potential for revenue growth.
Analysts have given Danaher Co. a consensus rating of "Moderate Buy" with a target price of $278.94, suggesting further upside potential.
Recent insider transactions, including senior executives buying and selling shares, indicate confidence in the company's future performance.
Danaher Co.'s strong financial position, with a market cap of $199.35 billion and low debt-to-equity ratio of 0.33, offers stability and room for strategic investments.

Danaher
Bear Case

Investors should be bearish about investing in Danaher Co. for these reasons:

The company's current P/E ratio of 46.48 and price-to-earnings-growth ratio of 4.48 may indicate an overvalued stock, potentially limiting short-term gains.
While insiders have been active in trading shares, the significant selling of company stock by insiders could raise concerns about future performance or market sentiment.
Danaher Co.'s beta of 0.83 suggests lower volatility compared to the market, which may limit potential returns for investors seeking higher-risk opportunities.
Despite positive analyst ratings, the stock has faced price target revisions, indicating uncertainty or differing opinions about the company's future growth prospects.
The company's 50-day and 200-day moving averages are close, potentially signaling a consolidation phase or lack of clear trend direction in the near term.

DHR Forecast - Frequently Asked Questions

: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Danaher is $281.06, with a high forecast of $315.00 and a low forecast of $250.00.
: 18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 6 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DHR shares.
: According to analysts, Danaher's stock has a predicted upside of 2.13% based on their 12-month stock forecasts.
: Danaher has been rated by research analysts at Bank of America, Barclays, Leerink Partners, Robert W. Baird, Royal Bank of Canada, Stephens, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Danaher less than other "multi-sector conglomerates" companies. The consensus rating score for Danaher is 2.67 while the average consensus rating score for "multi-sector conglomerates" companies is 2.74. Learn more on how DHR compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

PANIC IN THE BANKS: 63 on the Brink of Collapse (Ad)

63 banks are on the edge, drowning in $517 BILLION of unrealized losses. Interest rates are skyrocketing, and these institutions are cracking under the pressure.

Click Here To Get Your FREE Guide Now!

This page (NYSE:DHR) was last updated on 10/1/2024 by MarketBeat.com Staff

From Our Partners